THE GLOBAL AI IN THE MEDICAL IMAGING MARKET WAS VALUED AT USD 1.06 BILLION IN 2021 AND IS EXPECTED TO REACH USD 10.14 BILLION BY 2027, GROWING AT A CAGR OF 45.68%.

Global AI In Medical Imaging Market Size, Share, & Trends Analysis Report by

  • Technology: Deep Learning, NIP, and Others
  • Application: Neurology, Respiratory & Pulmonary, Cardiology, Breast Screening, Orthopedic, and Others
  • Modalities: CT, MRI, X-RAY, Ultrasound, and Nuclear Imaging
  • End-User: Hospitals, Diagnostic Imaging Centers, and Others
  • Geography: North America, Europe, APAC, Latin America, Middle East And Africa

Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

335 Pages

icon-table

88 Tables

icon-chart

169 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

34 Companies

icon-market

5 Market Segment

AI IN MEDICAL IMAGING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2021) USD 1.06 Billion
MARKET SIZE (2027) USD 10.14 Billion
CAGR (2022-2027) 45.68%
BASE YEAR 2021
FORECAST YEAR 2022-2027
LARGEST MARKET North America
FASTEST MARKET Asia Pacific
MARKET SEGMENTS Technology, Application, Modalities, and End-User
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East And Africa
COUNTRIES COVERED US, Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, UAE, and South Africa

MARKET INSIGHTS

The global AI in medical imaging market is projected to cross USD 10 billion by 2027, growing at a CAGR of 45% from USD 1.06 billion in 2021. AI in medical imaging has shown impressive accuracy and sensitivity in identifying abnormalities and promises to enhance tissue-based detection and characterization. One of the most promising areas of health innovation is the application of artificial intelligence (AI), mainly in medical imaging.

The constant increase in the number of diagnostic procedures and the decline in the number of radiologists, increasing work pressure on the radiologists, have increased the need for artificial intelligence adoption in the medical imaging space. The researchers are looking for multiple ways to implement artificial intelligence into medical imaging. The demand for artificial intelligence is constantly increasing in the medical imaging software market. From cardiac events, neurological conditions, fractures, or thoracic complications, artificial intelligence helps physicians to diagnose and provide treatment quickly. Implementing AI in medical imaging has enhanced medical screening, improved precision medicine software, reduced physicians' load, etc.

Technological Advancements Revolutionizing AI in Medical Imaging

  • There have been many technological advancements in AI-based medical imaging technologies, which have shown their increasing acceptance in high-income countries. Some of the improvements include the development of integrated rtiI software, which can directly be integrated into imaging equipment (MRI or CT scanner) which facilitates the automation of medical image analysis. Other advances include smartphone technology integration in AI in medical imaging in which front-line health workers could non-invasively screen for various conditions by leveraging a smartphone.
  • AI in medical imaging has drawn the attention of several radiologists worldwide. It gives faster and more accurate results and reduces diagnostic errors at reduced costs compared to traditional medical imaging methods. Thus, radiologists believe that AI in medical imaging may bring an enormous opportunity for its increasing implementation in the upcoming years.
  • In recent years, many large established companies, such as GE Healthcare and Siemens Healthineers, have enabled themselves to grow the AI in the medical imaging market by making huge investments for increasing partnerships and acquisitions. Other large healthcare-related or software companies not previously invested in health care, such as Thermo Fisher Scientific and Paraxel, have started making huge investments in the market.

Vendor's Activity in AI-Based Medical Imaging Market

Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips, and IBM Watson Health are the major players in the global AI in the medical imaging market. International players focus on developing innovative products with advanced technologies and expanding their product portfolio to remain competitive. They are continuously investing extensively in R&D to expand their product portfolio. Manufacturers such as GE Healthcare constantly focus on introducing new products with innovative technology platforms opening the platform (Edison Developer Program) for other companies offering artificial intelligence technologies to scale and deploy their developed applications across GE Healthcare's customer base.

Many major players are engaged in strategic acquisitions and partnerships that continue to be a competitive strategy for the key players, thus helping them grow inorganically. Innovative product approvals coupled with R&D activities are also helping the vendors to expand their presence, enhance growth, and sustain their position in the global market. In 2021, more than 30 countries approved AI in medical imaging technologies that are FDA and CE approved.

There is increasing funding and investments by public and private entities, including large companies, which is also one of the major driving factors of AI in the medical imaging market. For instance, more than 20 start-ups from various regions have received funds to develop AI-based medical imaging technologies.

GEOGRAPHY INSIGHTS

  • North America holds a dominant position in artificial intelligence in the medical imaging market. High adoption of advanced technologies is the primary factor for its larger industry share. In addition, the strong presence of the key players in the region is also a contributor to North America for holding a high market share.
  • Europe is the second-largest market for AI-based medical imaging. The presence of prominent market players and high healthcare spending are the primary factors for the significant market share in this region. The industry in Europe is mainly driven by the increasing collaborative research with extensive funding from the government. Increasing funding and investments are also driving the AI-based medical imaging market in the region.
  • The adoption rate of advanced artificial intelligence technologies in the medical imaging sector is still emerging in the Asia-pacific region. In recent years, there has been a noticeable investment and funding made by government and corporations and increasing collaborations and partnerships among the companies, research centers, and institutes. Due to these factors, the industry is growing exponentially in this region.
  • Lack of awareness of the importance of artificial intelligence in medical imaging, radiologists' job insecurity, a lack of sufficient IT infrastructure, a lack of proper training and knowledge among radiologists, concerns about data security, and a shortage of skilled professionals are all factors contributing to the industry's slow growth in Latin America, the Middle East, and Africa.
  • Among all the regions, APAC could witness the highest growth over the forecast period, with a CAGR of 51.06% in the global industry. The increasing prevalence of chronic diseases and diagnostic errors has opened enormous opportunities for APAC medical imaging AI market growth.

SEGMENTATION ANALYSIS

Hospitals are purchasing the artificial intelligence medical software suits as a complete package for the usage or taking up one program at a time which is used the most in the industry. The diagnostic imaging center's significant revenue generation is through imaging procedures, and they are primarily involved in implementing advanced products, which will attract customers. For instance, AI in medical imaging, along with clinical data, is helping physicians to predict heart attacks in patients accurately.

Neurology has accounted for the dominating share in the industry. The majority of the initial artificial intelligence product development focuses on downstream processing. This Downstream processing majorly includes artificial intelligence for segmentation, detecting anatomical structures, and quantifying a range of pathologies. Conditions like intracranial hemorrhage, ischemic stroke, primary brain tumors, cerebral metastases, and abnormal white matter signal intensities, which were unmet needs in the industry, has become commercially available solution within the radiology industry.

AI in medical imaging, especially cardiovascular magnetic resonance (CMR), is revolutionized by providing deep learning solutions, especially for image acquisitions, reconstructions, and analysis, which helps in supporting clinical decision-making. CMR is an established tool for routine clinical decision-making, including diagnosis, follow-up, real-time procedures, and pre-procedure planning.

Deep learning methods have enabled more tremendous success in medical image analysis. They have helped high accuracy, efficiency, stability, and scalability. Artificial intelligence tools have become assistive tools in medicine with benefits like error reduction, accuracy, fast computing, and better diagnostics. Natural language processing, Computer Vision, and Context-Aware Computing technologies are also used to create new analysis methods for medical imaging products.

In 2021, Philips showcased its new AI-enabled CT imaging portfolio. Their new CT 5100 with smart workflow application applies artificial intelligence at every step of CT image processing.

Siemens Healthineers's AI-Rad companion chest CT detects and highlights lung nodules. The tumor burden is automatically calculated. In addition, AI-Rad companion chest X-Ray played a significant role in patient management during the COVID-19 pandemic. The artificial intelligence-Rad companion file automatically processes upright chest X-ray images, pneumothorax, nodule detection, etc. This indicates the consolidations and atelectasis. This indicates the sign of pneumonia caused by the COVID-19 virus.

Artificial intelligence in CT scans and MRI dominated the industry, as much medical imaging using artificial intelligence tools falls into these modality categories. However, artificial intelligence in ultrasound and detecting mammography is largely adopted in the industry.

Frequently Asked Questions

HOW BIG IS THE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET?

The global AI in medical imaging market to reach USD 10.15 billion by 2027.

WHAT IS THE GROWTH RATE OF THE AI IN MEDICAL IMAGING MARKET?

The global AI-based medical imaging market is expected to grow at a CAGR of 45.68%.

WHO ARE THE KEY PLAYERS IN THE AI IN MEDICAL IMAGING MARKET?

The key player includes General Electric, Siemens Healthineers, Koninklijke Philips, and IBM Watson Health.

WHAT ARE THE LATEST TRENDS IN THE AI-BASED MEDICAL IMAGING MARKET?

The adoption of AI in medical imaging in developed countries and technological advancements are the latest trends in the industry.

WHICH REGION IS EXPECTED TO HOLD THE LARGEST SHARE IN THE AI-BASED MEDICAL IMAGING MARKET?

North America holds the largest share in the AI-based medical imaging market.

Download Free Sample

The global AI in medical imaging market is expected to grow at a CAGR of 45.68% during the forecast period 2022-2027.

The following factors are likely to contribute to the growth of artificial intelligence in medical imaging market during the forecast period:

  • Technological Advancements in AI-Based Medical Imaging
  • Rise in Number of Diagnostic Procedures
  • Expanding Investment & Business Activities of Vendors in AI-Based Medical Imaging
  • Growing Inclination of Radiologists Towards AI in medical imaging

Base Year: 2020

Forecast Year: 2021-2026

The report considers the present scenario of the global AI in medical imaging market and its market dynamics for the period 2021−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • General Electric
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Siemens Healthineers
  • Koninklijke Philips
  • IBM Watson Health

Other Prominent Vendors

  • Agfa-Gevaert Group/Agfa HealthCare
    • Business Overview
    • Product Offerings
  • Arterys
  • Avicenna.AI
  • AZmed
  • Butterfly Network
  • Caption Health
  • CellmatiQ
  • dentalXrai
  • Digital Diagnostics
  • EchoNous
  • GLEAMER
  • HeartVista
  • iCAD
  • Lunit
  • Mediaire
  • MEDO
  • Nanox Imaging
  • Paige AI
  • Perimeter Medical Imaging AI
  • Predible Health
  • 1QB Information Technology
  • Qure.ai
  • Quantib
  • QLARITY IMAGING
  • Quibim
  • Renalytix
  • Therapixel
  • Ultromics
  • Viz.ai
  • VUNO

Segmentation by Technology

  • Deep Learning
  • NIP
  • Others

Segmentation by Application

  • Neurology
  • Respiratory & Pulmonary
  • Cardiology
  • Breast Screening
  • Orthopedic
  • Others

Segmentation by Modalities

  • CT
  • MRI
  • X-RAY
  • Ultrasound
  • Nuclear Imaging

Segmentation by End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East And Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET BY TECHNOLOGY

4.3.2 MARKET BY APPLICATION

4.3.3 MARKET BY MODALITY

4.3.4 MARKET BY END USER

4.3.5 MARKET BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 BACKGROUND

7.2 ARTIFICIAL INTELLIGENCE IN HEALTHCARE INDUSTRY

7.3 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING

 

8 MARKET OPPORTUNITIES & TRENDS

8.1 TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING

8.2 INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES

8.3 GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING

 

9 MARKET GROWTH ENABLERS

9.1 RISE IN NUMBER OF DIAGNOSTIC PROCEDURES

9.2 EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING

9.3 RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS

9.4 DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS

 

10 MARKET RESTRAINTS

10.1 LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS

10.2 LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING

10.3 CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING

 

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 INSIGHTS BY TECHNOLOGY

11.2.2 INSIGHTS BY APPLICATION

11.2.3 INSIGHTS BY MODALITY

11.2.4 INSIGHTS BY END USER

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

 

12 TECHNOLOGY

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 DEEP LEARNING

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 MARKET BY GEOGRAPHY

12.4 NLP

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 MARKET BY GEOGRAPHY

12.5 OTHERS

12.5.1 MARKET OVERVIEW

12.5.2 MARKET SIZE & FORECAST

12.5.3 MARKET BY GEOGRAPHY

 

13 APPLICATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 NEUROLOGY

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 RESPIRATORY & PULMONARY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 CARDIOLOGY

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

13.6 BREAST CANCER

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 MARKET BY GEOGRAPHY

13.7 ORTHOPEDIC

13.7.1 MARKET OVERVIEW

13.7.2 MARKET SIZE & FORECAST

13.7.3 MARKET BY GEOGRAPHY

13.8 OTHERS

13.8.1 MARKET OVERVIEW

13.8.2 MARKET SIZE & FORECAST

13.8.3 MARKET BY GEOGRAPHY

 

14 MODALITY

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 CT

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 MRI

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 X-RAY

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 ULTRASOUND

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

14.7 NUCLEAR IMAGING

14.7.1 MARKET OVERVIEW

14.7.2 MARKET SIZE & FORECAST

14.7.3 MARKET BY GEOGRAPHY

 

15 END USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 HOSPITALS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 DIAGNOSTIC IMAGING CENTERS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

15.5 OTHERS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.5.3 MARKET BY GEOGRAPHY

 

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: TECHNOLOGY SEGMENTATION

17.4 NORTH AMERICA: APPLICATION SEGMENTATION

17.5 NORTH AMERICA: MODALITY SEGMENTATION

17.6 NORTH AMERICA: END-USER SEGMENTATION

17.7 KEY COUNTRIES

17.7.1 US: MARKET SIZE & FORECAST

17.7.2 CANADA MARKET SIZE & FORECAST

 

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 EUROPE: TECHNOLOGY SEGMENTATION

18.4 EUROPE: APPLICATION SEGMENTATION

18.5 EUROPE: MODALITY SEGMENTATION

18.6 EUROPE: END-USER SEGMENTATION

18.7 KEY COUNTRIES

18.7.1 GERMANY: MARKET SIZE & FORECAST

18.7.2 UK: MARKET SIZE & FORECAST

18.7.3 FRANCE: MARKET SIZE & FORECAST

18.7.4 ITALY: MARKET SIZE & FORECAST

18.7.5 SPAIN: MARKET SIZE & FORECAST

 

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 APAC: TECHNOLOGY SEGMENTATION

19.4 APAC: APPLICATION SEGMENTATION

19.5 APAC: MODALITY SEGMENTATION

19.6 APAC: END-USER SEGMENTATION

19.7 KEY COUNTRIES

19.7.1 CHINA: MARKET SIZE & FORECAST

19.7.2 INDIA: MARKET SIZE & FORECAST

19.7.3 JAPAN: MARKET SIZE & FORECAST

19.7.4 AUSTRALIA: MARKET SIZE & FORECAST

19.7.5 SOUTH KOREA: MARKET SIZE & FORECAST

 

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 LATIN AMERICA: TECHNOLOGY SEGMENTATION

20.4 LATIN AMERICA: APPLICATION SEGMENTATION

20.5 LATIN AMERICA: MODALITIES SEGMENTATION

20.6 LATIN AMERICA: END-USER SEGMENTATION

20.7 KEY COUNTRIES

20.7.1 BRAZIL: MARKET SIZE & FORECAST

20.7.2 MEXICO: MARKET SIZE & FORECAST

20.7.3 ARGENTINA: MARKET SIZE & FORECAST

 

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION

21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

21.5 MIDDLE EAST & AFRICA: MODALITIES SEGMENTATION

21.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

21.7 KEY COUNTRIES

21.7.1 TURKEY: MARKET SIZE & FORECAST

21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

21.7.3 UAE: MARKET SIZE & FORECAST

21.7.4 SOUTH AFRICA: MARKET SIZE & FORECAST

 

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.2 MARKET SHARE ANALYSIS

22.2.1 GENERAL ELECTRIC

22.2.2 SIEMENS HEALTHINEERS

22.2.3 KONINKLIJKE PHILIPS

22.2.4 IBM WATSON HEALTH

 

23 KEY COMPANY PROFILES

23.1 GENERAL ELECTRIC

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.1.3 KEY STRATEGIES

23.1.4 KEY STRENGTHS

23.1.5 KEY OPPORTUNITIES

23.2 SIEMENS HEALTHINEERS

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.2.3 KEY STRATEGIES

23.2.4 KEY STRENGTHS

23.2.5 KEY OPPORTUNITIES

23.3 KONINKLIJKE PHILIPS

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.3.3 KEY STRATEGIES

23.3.4 KEY STRENGTHS

23.3.5 KEY OPPORTUNITIES

23.4 IBM WATSON HEALTH

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.4.3 KEY STRATEGIES

23.4.4 KEY STRENGTHS

23.4.5 KEY OPPORTUNITIES

 

24 OTHER PROMINENT VENDORS

24.1 AGFA-GEVAERT GROUP

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.2 ARTERYS

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.3 AVICENNA.AI

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.4 AZMED

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.5 BUTTERFLY NETWORK

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERINGS

24.6 CAPTION HEALTH

24.6.1 BUSINESS OVERVIEW

24.6.2 PRODUCT OFFERINGS

24.7 CELLMATIQ

24.7.1 BUSINESS OVERVIEW

24.7.2 PRODUCT OFFERINGS

24.8 DENTALXRAI

24.8.1 BUSINESS OVERVIEW

24.8.2 PRODUCT OFFERINGS

24.9 DIGITAL DIAGNOSTICS

24.9.1 BUSINESS OVERVIEW

24.9.2 PRODUCT OFFERINGS

24.10 ECHONOUS

24.10.1 BUSINESS OVERVIEW

24.10.2 PRODUCT OFFERINGS

24.11 GLEAMER

24.11.1 BUSINESS OVERVIEW

24.11.2 PRODUCT OFFERINGS

24.12 HEARTVISTA

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.13 ICAD

24.13.1 BUSINESS OVERVIEW

24.13.2 PRODUCT OFFERINGS

24.14 LUNIT

24.14.1 BUSINESS OVERVIEW

24.14.2 PRODUCT OFFERINGS

24.15 MEDIAIRE

24.15.1 BUSINESS OVERVIEW

24.15.2 PRODUCT OFFERINGS

24.16 MEDO

24.16.1 BUSINESS OVERVIEW

24.16.2 PRODUCT OFFERINGS

24.17 NANOX IMAGING

24.17.1 BUSINESS OVERVIEW

24.17.2 PRODUCT OFFERINGS

24.18 PAIGE AI

24.18.1 BUSINESS OVERVIEW

24.18.2 PRODUCT OFFERINGS

24.19 PERIMETER MEDICAL IMAGING AI

24.19.1 BUSINESS OVERVIEW

24.19.2 PRODUCT OFFERINGS

24.20 PREDIBLE HEALTH

24.20.1 BUSINESS OVERVIEW

24.20.2 PRODUCT OFFERINGS

24.21 1QB INFORMATION TECHNOLOGIES

24.21.1 BUSINESS OVERVIEW

24.21.2 PRODUCT OFFERINGS

24.22 QURI.AI

24.22.1 BUSINESS OVERVIEW

24.22.2 PRODUCT OFFERINGS

24.23 QUANTIB

24.23.1 BUSINESS OVERVIEW

24.23.2 PRODUCT OFFERINGS

24.24 QLARITY IMAGING

24.24.1 BUSINESS OVERVIEW

24.24.2 PRODUCT OFFERINGS

24.25 QUIBIM

24.25.1 BUSINESS OVERVIEW

24.25.2 PRODUCT OFFERINGS

24.26 RENALYTIX

24.26.1 BUSINESS OVERVIEW

24.26.2 PRODUCT OFFERINGS

24.27 THERAPIXEL

24.27.1 BUSINESS OVERVIEW

24.27.2 PRODUCT OFFERINGS

24.28 ULTROMICS

24.28.1 BUSINESS OVERVIEW

24.28.2 PRODUCT OFFERINGS

24.29 VIZ.AI

24.29.1 BUSINESS OVERVIEW

24.29.2 PRODUCT OFFERINGS

24.30 VUNO

24.30.1 BUSINESS OVERVIEW

24.30.2 PRODUCT OFFERINGS

 

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

 

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY TECHNOLOGY

26.3 MARKET BY APPLICATION

26.4 MARKET BY MODALITY

26.5 MARKET BY END USER

26.6 NORTH AMERICA BY TECHNOLOGY

26.7 NORTH AMERICA BY APPLICATION

26.8 NORTH AMERICA BY MODALITY

26.9 NORTH AMERICA BY END USER

26.10 EUROPE BY TECHNOLOGY

26.11 EUROPE BY APPLICATION

26.12 EUROPE BY MODALITY

26.13 EUROPE BY END USER

26.14 APAC BY TECHNOLOGY

26.15 APAC BY APPLICATION

26.16 APAC BY MODALITY

26.17 APAC BY END USER

26.18 LATIN AMERICA BY TECHNOLOGY

26.19 LATIN AMERICA BY APPLICATION

26.20 LATIN AMERICA BY MODALITY

26.21 LATIN AMERICA BY END USER

26.22 MIDDLE EAST AND AFRICA BY TECHNOLOGY

26.23 MIDDLE EAST AND AFRICA BY APPLICATION

26.24 MIDDLE EAST AND AFRICA BY MODALITY

26.25 MIDDLE EAST AND AFRICA BY END USER

 

27 APPENDIX

27.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL AI-BASED MEDICAL IMAGING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 SECTORS CONTRIBUTING TO DEVELOPMENT OF HEALTHCARE IT

EXHIBIT 4 SCOPE OF AI IN MEDICAL IMAGING

EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING

EXHIBIT 6 IMPACT OF INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES

EXHIBIT 7 PERCENTAGE OF IMAGING CENTERS AND HOSPITALS IMPLEMENTING AI-BASED MEDICAL IMAGING DEVICES IN US 2019

EXHIBIT 8 IMPACT OF GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING

EXHIBIT 9 IMPACT OF RISE IN NUMBER OF DIAGNOSTIC PROCEDURES

EXHIBIT 10 GROWTH IN IMAGING ACTIVITY 2014/15 & 2018/19 (%)

EXHIBIT 11 DIAGNOSTIC PROCEDURES/TECHNIQUES USED IN AI STUDIES

EXHIBIT 12 IMPACT OF EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING

EXHIBIT 13 IMPACT OF RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS

EXHIBIT 14 IMPACT OF DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS

EXHIBIT 15 IMPACT OF LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS

EXHIBIT 16 IMPACT OF LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING

EXHIBIT 17 IMPACT OF CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING

EXHIBIT 18 GLOBAL AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 19 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021 & 2027 (%)

EXHIBIT 20 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021 & 2027 (%)

EXHIBIT 21 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021 & 2027 (%)

EXHIBIT 22 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END-USER 2021 & 2027 (%)

EXHIBIT 23 FIVE FORCES ANALYSIS 2021

EXHIBIT 24 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 25 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY

EXHIBIT 26 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 27 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: ABSOLUTE GROWTH (%)

EXHIBIT 28 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 29 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING 2021–2027 ($ MILLION)

EXHIBIT 30 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 31 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP 2021–2027 ($ MILLION)

EXHIBIT 32 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 34 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 35 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES 2021–2027 ($ MILLION)

EXHIBIT 36 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 37 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 38 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION

EXHIBIT 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: ABSOLUTE GROWTH (%)

EXHIBIT 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY 2021–2027 ($ MILLION)

EXHIBIT 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY 2021–2027 ($ MILLION)

EXHIBIT 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY AND PULMONARY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY 2021–2027 ($ MILLION)

EXHIBIT 49 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 50 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 51 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING 2021–2027 ($ MILLION)

EXHIBIT 52 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 53 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 54 MOST STUDIED ORTHOPEDIC AREAS FOR AI-BASED IMAGE INTERPRETATION (%)

EXHIBIT 55 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC 2021–2027 ($ MILLION)

EXHIBIT 56 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 58 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS 2021–2027 ($ MILLION)

EXHIBIT 59 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 60 INCREMENTAL GROWTH BY MODALITY 2021 & 2027

EXHIBIT 61 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY

EXHIBIT 62 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 63 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: ABSOLUTE GROWTH (%)

EXHIBIT 64 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT 2021–2027 ($ MILLION)

EXHIBIT 65 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 66 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 67 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI 2021–2027 ($ MILLION)

EXHIBIT 69 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 70 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 71 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY 2021–2027 ($ MILLION)

EXHIBIT 72 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 73 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 74 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND 2021–2027 ($ MILLION)

EXHIBIT 75 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 76 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING 2021–2027 ($ MILLION)

EXHIBIT 77 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 78 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 80 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER

EXHIBIT 81 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 82 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: ABSOLUTE GROWTH (%)

EXHIBIT 83 PERCENTAGE OF ANNUAL EXAMINATIONS PER RADIOLOGY DEPARTMENT IN US

EXHIBIT 84 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 85 DIAGNOSTIC ERRORS IN DIFFERENT AREAS IN FINLAND (%)

EXHIBIT 86 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS 2021–2027 ($ MILLION)

EXHIBIT 87 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 88 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTER: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 89 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS 2021–2027 ($ MILLION)

EXHIBIT 90 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 91 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 92 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS 2021–2027 ($ MILLION)

EXHIBIT 93 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 94 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 95 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY

EXHIBIT 96 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 97 GLOBAL AI-BASED MEDICAL IMAGING BY GEOGRAPHY: ABSOLUTE GROWTH (%)

EXHIBIT 98 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 99 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 100 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 101 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 103 INCREMENTAL GROWTH BY MODALITY 2021 & 2027

EXHIBIT 104 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 105 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 106 US AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 107 CANADA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 108 EUROPE AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 109 EUROPE AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 110 EUROPE AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 111 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 112 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 113 INCREMENTAL GROWTH BY MODALITY 2021 & 2027

EXHIBIT 114 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 115 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 116 GERMANY AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 117 UK AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 118 FRANCE AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 119 MEDICAL IMAGING ACTIVITIES IN ITALY (%)

EXHIBIT 120 ITALY AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 121 SPAIN AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 122 APAC AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 123 APAC AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 124 APAC AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 125 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 126 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 127 INCREMENTAL GROWTH BY MODALITY 2021 & 2027

EXHIBIT 128 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 129 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 130 CHINA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 131 AI-BASED MEDICAL IMAGING MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 132 JAPAN AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 133 AUSTRALIA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 134 AI-BASED MEDICAL IMAGING MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 135 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 136 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 137 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 138 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 139 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 140 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027

EXHIBIT 141 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 142 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 143 BRAZIL AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 144 MEXICO AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 145 ARGENTINA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 146 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 147 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 148 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 149 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 150 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 151 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027

EXHIBIT 152 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 153 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 154 AI-BASED MEDICAL IMAGING MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 155 SAUDI ARABIA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 156 UAE AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 157 SOUTH AFRICA AI-BASED MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)

EXHIBIT 158 PURE & DIVERSIFIED COMPANIES IN GLOBAL AI-BASED MEDICAL IMAGING MARKET

EXHIBIT 159 GLOBAL AI-BASED MEDICAL IMAGING MARKET: MARKET DOMINANCE ANALYSIS

EXHIBIT 160 VENDORS IN GLOBAL AI-BASED MEDICAL IMAGING MARKET: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 161 GENERAL ELECTRIC: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 162 GENERAL ELECTRIC: TOTAL REVENUE BY HEALTHCARE SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 163 GENERAL ELECTRIC: R&D EXPENDITURE IN HEALTHCARE SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 164 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 165 SIEMENS HEALTHINEERS: TOTAL REVENUE BY IMAGING SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 166 KONINKLIJKE PHILIPS: REVENUE BY DIAGNOSIS AND TREATMENT BUSINESS 2019–2021 ($ MILLION)

EXHIBIT 167 KONINKLIJKE PHILIPS: R&D EXPENDITURE IN DIAGNOSIS AND TREATMENT BUSINESS SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 168 IBM: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 169 IBM: TOTAL R&D EXPENDITURE ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 START-UPS INVOLVED IN DEVELOPMENT OF AI-BASED MEDICAL IMAGING

TABLE 4 LIST OF FDA-APPROVED AI-BASED MEDICAL IMAGING PLATFORMS

TABLE 5 GENERAL ELECTRIC: MAJOR PRODUCT OFFERINGS

TABLE 6 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS

TABLE 7 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 8 IBM: MAJOR PRODUCT OFFERINGS

TABLE 9 AGFA-GEVAERT GROUP: MAJOR PRODUCT OFFERINGS

TABLE 10 ARTERYS: MAJOR PRODUCT OFFERINGS

TABLE 11 AVICENNA.AI: MAJOR PRODUCT OFFERINGS

TABLE 12 AZMED: MAJOR PRODUCT OFFERINGS

TABLE 13 BUTTERFLY NETWORK: MAJOR PRODUCT OFFERINGS

TABLE 14 CAPTION HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 15 CELLMATIQ: MAJOR PRODUCT OFFERINGS

TABLE 16 DENTALXRAI: MAJOR PRODUCT OFFERINGS

TABLE 17 DIGITAL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 18 ECHONOUS: MAJOR PRODUCT OFFERINGS

TABLE 19 GLEAMER: MAJOR PRODUCT OFFERINGS

TABLE 20 HEARTVISTA: MAJOR PRODUCT OFFERINGS

TABLE 21 ICAD: MAJOR PRODUCT OFFERINGS

TABLE 22 LUNIT: MAJOR PRODUCT OFFERINGS

TABLE 23 MEDIAIRE: MAJOR PRODUCT OFFERINGS

TABLE 24 MEDO: MAJOR PRODUCT OFFERINGS

TABLE 25 NANOX IMAGING: MAJOR PRODUCT OFFERINGS

TABLE 26 PAIGE AI: MAJOR PRODUCT OFFERINGS

TABLE 27 PERIMETER MEDICAL IMAGING AI: MAJOR PRODUCT OFFERINGS

TABLE 28 PREDIBLE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 29 1QB INFORMATION TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 30 QURE.AI: MAJOR PRODUCT OFFERINGS

TABLE 31 QUANTIB: MAJOR PRODUCT OFFERINGS

TABLE 32 QLARITY IMAGING: MAJOR PRODUCT OFFERINGS

TABLE 33 QUIBIM: MAJOR PRODUCT OFFERINGS

TABLE 34 RENALYTIX: MAJOR PRODUCT OFFERINGS

TABLE 35 THERAPIXEL: MAJOR PRODUCT OFFERINGS

TABLE 36 ULTROMICS: MAJOR PRODUCT OFFERINGS

TABLE 37 VIZ.AI: MAJOR PRODUCT OFFERINGS

TABLE 38 VUNO: MAJOR PRODUCT OFFERINGS

TABLE 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

TABLE 49 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 50 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 51 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 52 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 53 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 54 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 55 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 56 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

TABLE 57 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 58 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 59 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 60 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 61 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 62 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 63 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 64 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

TABLE 65 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 66 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 67 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 68 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 69 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 70 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 71 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 72 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

TABLE 73 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 74 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 75 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 76 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 77 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 78 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 79 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 80 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

TABLE 81 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 ($ MILLION)

TABLE 82 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 83 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 84 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021–2027 (%)

TABLE 85 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)

TABLE 86 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)

TABLE 87 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 ($ MILLION)

TABLE 88 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date